Romidepsin-related toxicities occurring in more than 15% of patients
| . | Grade 1 . | Grade 2 . | Grade 3 . | Grade 4 . | Total . |
|---|---|---|---|---|---|
| Nausea | 20 | 3 | 0 | 0 | 23 |
| Fatigue | 16 | 5 | 1 | 0 | 22 |
| Anemia | 8 | 4 | 4 | 0 | 16 |
| Neutrophil count decreased | 2 | 5 | 5 | 3 | 15 |
| Platelet count decreased | 10 | 1 | 2 | 2 | 15 |
| White blood cells decreased | 5 | 6 | 3 | 1 | 15 |
| Dysgeusia | 9 | 4 | 0 | 0 | 13 |
| Lymphocyte count decreased | 2 | 1 | 5 | 2 | 10 |
| Aspartate aminotransferase increased | 6 | 1 | 1 | 0 | 8 |
| Blood bilirubin increased | 3 | 3 | 1 | 0 | 7 |
| Hyperglycemia | 3 | 2 | 2 | 0 | 7 |
| Alanine aminotransferase increased | 4 | 1 | 1 | 0 | 6 |
| Vomiting | 5 | 1 | 0 | 0 | 6 |
| Anorexia | 2 | 3 | 0 | 0 | 5 |
| Constipation | 4 | 1 | 0 | 0 | 5 |
| Generalized muscle weakness | 4 | 0 | 1 | 0 | 5 |
| Hypoalbuminemia | 2 | 3 | 0 | 0 | 5 |
| Upper respiratory infection | 1 | 4 | 0 | 0 | 5 |
| . | Grade 1 . | Grade 2 . | Grade 3 . | Grade 4 . | Total . |
|---|---|---|---|---|---|
| Nausea | 20 | 3 | 0 | 0 | 23 |
| Fatigue | 16 | 5 | 1 | 0 | 22 |
| Anemia | 8 | 4 | 4 | 0 | 16 |
| Neutrophil count decreased | 2 | 5 | 5 | 3 | 15 |
| Platelet count decreased | 10 | 1 | 2 | 2 | 15 |
| White blood cells decreased | 5 | 6 | 3 | 1 | 15 |
| Dysgeusia | 9 | 4 | 0 | 0 | 13 |
| Lymphocyte count decreased | 2 | 1 | 5 | 2 | 10 |
| Aspartate aminotransferase increased | 6 | 1 | 1 | 0 | 8 |
| Blood bilirubin increased | 3 | 3 | 1 | 0 | 7 |
| Hyperglycemia | 3 | 2 | 2 | 0 | 7 |
| Alanine aminotransferase increased | 4 | 1 | 1 | 0 | 6 |
| Vomiting | 5 | 1 | 0 | 0 | 6 |
| Anorexia | 2 | 3 | 0 | 0 | 5 |
| Constipation | 4 | 1 | 0 | 0 | 5 |
| Generalized muscle weakness | 4 | 0 | 1 | 0 | 5 |
| Hypoalbuminemia | 2 | 3 | 0 | 0 | 5 |
| Upper respiratory infection | 1 | 4 | 0 | 0 | 5 |